MMS is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. With an 18-year track record, AI technology-enabled services, and a data-driven approach to drug development, MMS maintains an industry-leading customer satisfaction rating. The company operates globally across four continents, providing valuable CRO services to its clients.
Founded in 2006, MMS has built a reputation for its strong industry experience, innovative solutions, and commitment to excellence. The company's focus on leveraging AI technology and data analytics sets it apart in the competitive CRO landscape.
For more information, visit www.mmsholdings.com.
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
| Ownership Private Company |
B2B professionals should contact <strong class="text-white font-semibold">MMS</strong> for its expertise in clinical research, AI-driven data solutions, and proven track record in the pharmaceutical and biotech industries. The company offers valuable partnerships and vendor opportunities for those seeking to enhance their drug development processes.
Sales teams selling CRO services, pharmaceutical and biotech companies, and AI technology vendors should reach out to <strong class="text-white font-semibold">MMS</strong>. The company also attracts recruiters seeking roles in clinical research and data analytics.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with MMS